Insider · CIK 0001625110
Allison Dorval
Files at PBYI (PUMA BIOTECHNOLOGY, INC.), VERV (Verve Therapeutics, Inc.). First filing Dec 3, 2024, latest Jun 17, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PBYI: PUMA BIOTECHNOLOGY, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 21Weak | PUMA BIOTECHNOLOGY, INC. | $39k 11,610 shares | -13% | +38% from low-10% from high | |
| 7Weak | Verve Therapeutics, Inc. | $14k 3,350 shares | -20% | - | |
| 7Weak | VERVsell Verve Therapeutics, Inc. | $3,130 555 shares | -9% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | UTender of shares Common Stock | -13,280 | - | - | 0 | Jul 28, 2025 |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -258,000 | - | - | 0 | Jul 28, 2025 |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -75,000 | - | - | 0 | Jul 28, 2025 |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | DDisposition to issuer Restricted Stock Unitsderivative | -45,000 | - | - | 0 | Jul 28, 2025 |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | DDisposition to issuer Restricted Stock Unitsderivative | -33,750 | - | - | 0 | Jul 28, 2025 |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | DDisposition to issuer Restricted Stock Unitsderivative | -1,875 | - | - | 0 | Jul 28, 2025 |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -180,000 | - | - | 0 | Jul 28, 2025 |
| Jun 13, 2025 | PBYI PUMA BIOTECHNOLOGY, INC. | SOpen-market sale Common Stock10b5-1 | -11,610 | $3.40 | $39k | 75,390 | Jun 17, 2025 |
| Jun 11, 2025 | PBYI PUMA BIOTECHNOLOGY, INC. | AGrant or award Common Stock | +27,000 | $0.00 | $0 | 87,000 | Jun 13, 2025 |
| Apr 1, 2025 | VERV Verve Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +11,250 | - | - | 16,630 | Apr 3, 2025 |
| Apr 2, 2025 | VERV Verve Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -3,350 | $4.15 | $14k | 13,280 | Apr 3, 2025 |
| Apr 1, 2025 | VERV Verve Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative10b5-1 | -11,250 | $0.00 | $0 | 33,750 | Apr 3, 2025 |
| Jan 8, 2025 | VERV Verve Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +258,000 | $0.00 | $0 | 258,000 | Jan 10, 2025 |
| Jan 8, 2025 | VERV Verve Therapeutics, Inc. | AGrant or award Restricted Stock Unitsderivative | +45,000 | $0.00 | $0 | 45,000 | Jan 10, 2025 |
| Jan 8, 2025 | VERV Verve Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +75,000 | $0.00 | $0 | 75,000 | Jan 10, 2025 |
| Nov 29, 2024 | VERV Verve Therapeutics, Inc. | MOption exercise Common Stock | +1,875 | - | - | 5,935 | Dec 3, 2024 |
| Dec 2, 2024 | VERV Verve Therapeutics, Inc. | SOpen-market sale Common Stock | -555 | $5.64 | $3,130 | 5,380 | Dec 3, 2024 |
| Nov 29, 2024 | VERV Verve Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative | -1,875 | $0.00 | $0 | 1,875 | Dec 3, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.